Insilico Open-Sources 24/7 Personal Longevity Superintelligence to Turn Quantified-Self Data into Predictive Health States and Aging Research

CAMBRIDGE, Mass., Nov. 6, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage generative AI drug discovery company, today announced the open-source release of Longevity Grok, the Personal Longevity Superintelligence (PLSI) and launched the website longevitygrok.si, in collaboration...

Read the full story at Insilico Medicine via PR Newswire (opens in a new tab)

Headline and summary from Insilico Medicine via PR Newswire; the full story is on the publisher's site. Nothing here is investment advice.